ABRIZYL owner Contact Information online
from Novartis AG
ABRIZYL
US serial number:85194130
Application filling date:Dec. 09, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jul. 14, 2014
Publication date:Apr. 12, 2011
Abandoned date:Jul. 14, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Anti-infectives; Antibiotic preparations; Antifungal preparations; Antivirals; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidne
Current owner owner name:Novartis AG
Current owner owner address:CH-4002
Basel
SWITZERLAND
Current owner legal entity type:CORPORATION
Current owner state or country:SWITZERLAND
Attorney name:Maury M. Tepper, III
Attorney email:mtepper@teiplaw.com
Attorney email authorized:Yes
Correspondent name address:MAURY M. TEPPER, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH,
NORTH CAROLINA
UNITED STATES
27609-7321
Correspondent phone:919-861-8903
Correspondent email:mtepper@teiplaw.com
Correspondent fax:919-861-8913
Correspondent email authorized:Yes
Domestic representative name:Novartis Pharmaceuticals Corporation
Domestic representative phone:919-861-8903
Domestic representative fax:919-861-8913
Trademark staff tm attorney:GOODSAID, IRA J
Trademark staff law office assigned ABRIZYL:LAW OFFICE 101
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (150) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) SANOFI (46) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (37) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Ares Trading S.A. (17) Scott Riddell (17)Popular publication dates
Apr. 12, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Oct. 05, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011
